Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Little Green Pharma Ltd. ( (AU:LGP) ) has issued an announcement.
Little Green Pharma Ltd announced a change in the director’s interest, with Paul Long acquiring 2,000,000 options under the company’s Long Term Incentive Plan. This acquisition, approved by shareholders, reflects the company’s ongoing commitment to aligning leadership incentives with shareholder interests, potentially impacting the company’s strategic direction and market performance.
The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.18 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd operates in the pharmaceutical industry, focusing on the production and distribution of medical cannabis products. The company aims to provide innovative therapeutic solutions and is positioned to serve both domestic and international markets.
Average Trading Volume: 153,872
Technical Sentiment Signal: Buy
Current Market Cap: A$37.34M
Learn more about LGP stock on TipRanks’ Stock Analysis page.